ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.625
-0.03%
Brent Oil
76.495
0.00%
Bitcoin
98,511.01
0.31%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Alemania
  5. TG

  6. Mvise AG (C1V) Cotización

Mvise AG

Mvise AG (C1V)

TG
0.336
-0.006
(-1.75%)
Cerrado 05 Enero 3:00PM
Realtime Data

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
0.336
Postura de Compra
0.248
Postura de Venta
0.422
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
3.328M
Precio Anterior
0.342
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
9,905,351
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.98
Beneficio por acción (BPA)
-0.35
turnover
14.42M
Beneficio neto
-3.42M

Acerca de Mvise AG

Sector
Communications Services, Nec
Industria
Communications Services, Nec
Sitio web
mvise.de
Sede
Duesseldorf, Deu
Fundado
-
Mvise AG is listed in the Communications Services sector of the Tradegate (DE) with ticker C1V. The last closing price for Mvise was 0.34 €. Over the last year, Mvise shares have traded in a share price range of 0.00 € to 0.00 €.

Mvise currently has 9,905,351 shares in issue. The market capitalisation of Mvise is 3.39 € million. Mvise has a price to earnings ratio (PE ratio) of -0.98.

C1V Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

C1V - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Mvise?
El precio actual de las acciones de Mvise es 0.336 €
¿Cuántas acciones de Mvise están en circulación?
Mvise tiene 9,905,351 acciones en circulación
¿Cuál es la capitalización de mercado de Mvise?
La capitalización de mercado de Mvise es EUR 3.39M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Mvise?
Mvise ha negociado en un rango de 0.00 € a 0.00 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Mvise?
El ratio precio/beneficio de Mvise es -0.98
¿Cuál es el ratio de efectivo a ventas de Mvise?
El ratio de efectivo a ventas de Mvise es 0.23
¿Cuál es la moneda de reporte de Mvise?
Mvise presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Mvise?
El último ingresos anual de Mvise es EUR 14.42M
¿Cuál es el último beneficio anual de Mvise?
El último beneficio anual de Mvise es EUR -3.42M
¿Cuál es la dirección registrada de Mvise?
La dirección registrada de Mvise es STADTTOR 1, DUESSELDORF, 40219
¿Cuál es la dirección del sitio web de Mvise?
La dirección del sitio web de Mvise es mvise.de
¿En qué sector industrial opera Mvise?
Mvise opera en el sector COMMUNICATIONS SERVICES, NEC

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
0S6Cerence Inc
18.972 €
(145.34%)
90.04k
CY9DMicrobot Medical Inc
2.11 €
(89.07%)
24.21k
RV0Torrent Gold Inc
0.138 €
(73.58%)
1.23k
7CCCheckCap Ltd
1.76 €
(55.75%)
6.55k
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M
FASFastenal Co
9.7358 €
(-85.95%)
2.13k
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-45.45%)
300.18k
B4T0CuFe Ltd
0.0045 €
(-25.00%)
1
H5EHelma Eigenheimbau Ag
0.0766 €
(-23.40%)
751
2WOWide Open Agriculture Ltd
0.005 €
(-23.08%)
50k
PF8European Lithium Limited
0.0264 €
(8.20%)
5.76M
3CPXiaomi Corporation
4.597 €
(7.34%)
3.95M
D7GNel ASA
0.247 €
(2.66%)
2.33M
J9AVERSES AI Inc
1.352 €
(0.00%)
1.67M
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M

Discusión

Ver feed completo
Jahvik Jahvik 3 minutos hace
Really?
Is that all that you read?
Keep trying 
HMBL
lizzy241 lizzy241 3 minutos hace
Mr Stockboy, the company stated a few months ago that the buyback would be put on hold until further notice.
AMRN
JR30 JR30 4 minutos hace
"Scummy way of sticking your finger in the eyes of those whose retirement plans got wiped out…    That makes you feel good?"

Not as scummy as shorty and those that supposedly got their retirement plans wiped out trying to make the value of their investment go down by posting negative
VERB
Glycobio Glycobio 5 minutos hace
Your quote does not refute or cancel out the conclusion from Dr. Chalasani, who is looking at all the data in great detail (more than what we have access to). His conclusion of reproducible benefit is a strong statement for significant value of belapectin in cirrhosis.

Not sure why y
GALT
capgain capgain 6 minutos hace
It's not supposed to stop snowing there until midnight tomorrow night, according to my weather. It's going to be a big one.
Hoskuld Hoskuld 8 minutos hace
It is good that you pointed out that the trials were in Australia, Canada, UK, Germany, and the Netherlands and the duration was 48 weeks per protocol. Also good that you pointed out that the 58 fully accredited authors independently wrote the paper and analyzed the data. The next 2 weeks should b
AVXL
Top Penny Top Penny 8 minutos hace
https://x.com/TruestoneL52236
PSRU
pantherj pantherj 8 minutos hace
As usual, you try to change the subject because you cannot deal with the facts.
IFUS
Gnewton14 Gnewton14 8 minutos hace
Optimistic speculation it's all connected. 8 days to launch with SpaceX and there's a $1.5 billion defense announcement? Now that'd be something 
LAES
Tr8dervic Tr8dervic 8 minutos hace
Powerball Winning Numbers
Sat, Jan 4, 2025
26
32
43
54
56
24
Power Play
2x
Estimated Jackpot: $206 Million
Cash Value: $92.1 Million

Next Drawing
Mon, Jan 6, 2025
Estimated Jackpot
$220
100lbStriper 100lbStriper 8 minutos hace
lol!!! thats not funny, it may actually happen!!! man its been an eternity since i've heard that!!!
NLST
Homebrew Homebrew 9 minutos hace
Wow...Guerguerian's a real scumbag. He posted on Linked in to sucker newbies into his gambling scheme.
ERHE
ducci1 ducci1 9 minutos hace
Roger That! Fun Sharing What others Have Shared With Me Over The Years !! ( Also Keeps My Old Brain Excercised !! )
SPY
vdog1776 vdog1776 9 minutos hace
Yeah, we all don’t read. I know everything’s bad everything’s negative! So why are you here again then?
VXIT
sunspotter sunspotter 10 minutos hace
There’s every reason to believe IPIX no longer has any stake in BeaMed, and literally no logical reason to believe otherwise.
IPIX
IH Admin [Shelly] IH Admin [Shelly] 12 minutos hace
Alright, folks, you need to get back to talking about AZRH without all the attacks. There are quite a few of who are a deletion or two away from restrictions, so please heed this warning.

Mods, you should be removing posts like these, not responding in kind.
AZRH
camelion camelion 12 minutos hace
If you bring this info up via X in a direct message to the company. then you might get productive responses instead with the other.
HIRU
prototype_101 prototype_101 12 minutos hace
teddybear said, I’m so honored by your post and by how many people agreed with you

Ok teddybear, so since you love Dreamtravbelgium's post celebrating YOU so much, how about making a public recommendation to replace your current Yellow Sticky post #20676&
ASM LWLG
sunspotter sunspotter 12 minutos hace
Actually this quote sums up the whole situation perfectly:

“ While there was a favorable trend for incidence of varices in the primary end point intent-to-treat population, belapectin did not achieve statistical significance”

And not only do I understand pharmaceutical
GALT
Atown62 Atown62 12 minutos hace
Nobody is more entertained then you Imafan when the ceo is dressing up, or visiting your coffee shop
HHSE
nowwhat2 nowwhat2 13 minutos hace
Hang in there XPArmy......Don't let the fear mongerers drive nails into your head.
Just smash the Moe Like Button instead.


https://www.youtube.com/watch?v=D5oX1D8t6Ng





We are number one in XRP Army Land !

XRPUSD
Iggy_Bot Iggy_Bot 14 minutos hace
For sure a couple more cycles and most will probably be gone
Slow waiter Slow waiter 14 minutos hace
Slow waiter has been waiting a long time.
Now, I want to hear news of progress. I would like to hear news soon. This no news business is not far to us long timers.
TMMI
Smattchew Smattchew 14 minutos hace
"Some of you guys" also includes yourself, mcbot. Six or whatever many years it has been now, and not a lick of abandonment. Have a great Sunday, and enjoy this conversation about fka $bioaq it's the same one you've had forever and forever. It's impressive how much you care about a dead company!
BIOAQ

Su Consulta Reciente

TG
C1V
Mvise
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados